Pacific Biosciences of California (PACB)
$1.64 2.5%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
1 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Pacific Biosciences of California, AI stock picks, stock alerts and much more.
PACB AI Stock Analysis
AI stock analysis for PACB is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Pacific Biosciences of California (PACB) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
PACB Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Pacific Biosciences of California (PACB), currently trading at $1.64, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About PACB
-
Pacific Biosciences of California, Inc.
-
Symbol
PACB
-
Market
NASDAQ
-
Industry
Medical - Devices
-
Market Cap
449.1M
Similar Stocks
 |
Align Technology ALGN |
$224.2 2.4% |
5 |
 |
iRhythm Technologies IRTC |
$108.3 1.3% |
4 |
 |
Silk Road Medical SILK |
$27.49 0% |
6 |
 |
Cutera CUTR |
$0.477 19.2% |
2 |
 |
Dexcom DXCM |
$84.38 0.5% |
4 |
News
PACB Alternative Data
News Mentions
Sign up to access
Twitter Followers
Sign up to access
Facebook Engagement
Sign up to access
Youtube Subscribers
Sign up to access
LinkedIn Followers
Sign up to access
Job Postings
Sign up to access
LinkedIn Employees
Sign up to access
Web Traffic
Sign up to access
Business Outlook
Sign up to access
PACB Financials
PACB Key Metrics
-
Total Revenue
$40M
-
Net Income
-$60.7M
-
Earnings per Share
-$0.22
-
Free cash flow
-$44.7M
-
EBITDA
-$41.1M
-
EBITDA Ratio
-1.02805
-
Total Assets
$1.5B
PACB 2-year Revenue & Income
PACB 2-year Free Cash Flow
PACB Technicals
PACB SMA
PACB RSI
FAQ
What's the current price of Pacific Biosciences of California (PACB) Stock?
The price of an Pacific Biosciences of California (PACB) share is $1.64.
What's the market cap of Pacific Biosciences of California?
The current market cap of Pacific Biosciences of California is 449.1M.
Should I buy or sell PACB?
Pacific Biosciences of California exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Pacific Biosciences of California a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Pacific Biosciences of California stock. There are several bearish signals and market challenges that could negatively impact Pacific Biosciences of California's future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Pacific Biosciences of California (PACB) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Pacific Biosciences of California stock right now, as the outlook appears bearish.
What are some stocks similar to Pacific Biosciences of California (PACB) that investors often compare it to?
Pacific Biosciences of California (PACB) is often compared to similar stocks such as Align Technology, iRhythm Technologies, Silk Road Medical, Cutera and Dexcom.
What is the forecast for Pacific Biosciences of California's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Pacific Biosciences of California's stock price to be around $1.53 in 2026. Starting from the current price of $1.64, this represents a 6.5% change in price, indicating a bearish outlook for the stock.
How to buy Pacific Biosciences of California (PACB) Stock?
Pacific Biosciences of California stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Pacific Biosciences of California shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.